MEDIFAST INC
MEDNYSE
$10.26
↓ -2.3%Jul 17 close · end-of-day
Price
1Y↓ -24.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$112.9M
Enterprise Value
-$56.0M
P/E
—
P/S
0.3
P/B
0.6
EV/EBITDA
—
PEG
—
FCF Yield
-1.3%
Dividend Yield
—
Revenue (TTM)
$346.1M
Net Income (TTM)
-$20.4M
Free Cash Flow (TTM)
-$1.5M
Gross Margin
70.1%
Operating Margin
-4.7%
Net Margin
-5.9%
ROE
-10.3%
ROIC
-44.7%
Debt / Equity
—
Net Cash
$168.9M
Return 1Y
-23.7%
Company profile
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
- CEO
- Daniel R. Chard
- Sector
- Manufacturing
- Industry
- Food Products
- Employees
- 870
- Headquarters
- Maryland
- Website
- medifastinc.com
Management & directors
- Chard Daniel RChairman & CEO
- Mackenzie Jonathan BarrettVP, Finance & CAO
- Maloney James P.Chief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
MED Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$76.0M↓ -34.3%
Diluted EPS-$0.19↑ +171.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | $385.8M |
| Gross profit | $697.8M | $1.1B | $1.1B | $775.9M | $444.6M | $275.2M |
| Operating income | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | -$14.2M |
| Net income | $102.9M | $164.0M | $144.0M | $99.0M | $2.0M | -$19.0M |
| Diluted EPS | $8.68 | $13.89 | $12.73 | $9.10 | $0.19 | -$1.70 |
| Operating cash flow | $145.2M | $94.5M | $194.6M | $147.7M | $24.5M | $6.9M |
| Free cash flow | $139.3M | $60.3M | $177.9M | $141.2M | $17.0M | $1.2M |
| Gross margin | 74.6% | 73.9% | 71.3% | 72.4% | 73.8% | 71.3% |
| Operating margin | 14.4% | 14.2% | 11.6% | 11.8% | 0.5% | -3.7% |
| Net margin | 11.0% | 10.7% | 9.0% | 9.2% | 0.3% | -4.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $168.6M | $140.2M | $119.0M | $115.7M | $105.6M | $89.4M | $75.1M | $76.0M |
| Gross profit | $123.4M | $105.7M | $88.2M | $84.2M | $76.6M | $62.2M | $52.1M | $51.8M |
| Operating income | -$7.9M | $2.1M | $708,000.00 | -$1.3M | -$1.1M | -$4.1M | -$7.8M | -$3.3M |
| Net income | -$8.2M | $1.1M | $709,000.00 | -$772,000.00 | $2.5M | -$2.3M | -$18.4M | -$2.1M |
| Diluted EPS | -$0.75 | $0.10 | $0.08 | -$0.07 | $0.22 | -$0.21 | -$1.64 | -$0.19 |
| Operating cash flow | $13.1M | $9.1M | -$4.9M | $3.4M | -$3.4M | $12.1M | -$5.3M | $260,000.00 |
| Free cash flow | $11.1M | $7.7M | -$7.2M | $1.9M | -$4.8M | $10.8M | -$6.6M | -$836,000.00 |
| Gross margin | 73.2% | 75.4% | 74.1% | 72.8% | 72.6% | 69.5% | 69.4% | 68.1% |
| Operating margin | -4.7% | 1.5% | 0.6% | -1.1% | -1.0% | -4.6% | -10.4% | -4.3% |
| Net margin | -4.8% | 0.8% | 0.6% | -0.7% | 2.3% | -2.5% | -24.6% | -2.8% |
Company news
Jul 20, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-26 | Kiai Parsa | Award | 11,680 | $0.00 | $0.00 | filing |
| 2026-05-26 | Kiai Parsa | Award | 7,637 | $0.00 | $0.00 | filing |
| 2026-05-26 | Rose Jeffrey Matthew | Award | 11,680 | $0.00 | $0.00 | filing |
| 2026-05-26 | Thomas Andrea B | Award | 11,680 | $0.00 | $0.00 | filing |
| 2026-05-26 | SCHLACKMAN SCOTT | Award | 11,680 | $0.00 | $0.00 | filing |
| 2026-05-26 | Geary Elizabeth A. | Award | 11,680 | $0.00 | $0.00 | filing |
| 2026-05-26 | Rose Jeffrey Matthew | Award | 6,739 | $0.00 | $0.00 | filing |
| 2026-05-11 | SCHLACKMAN SCOTT | Buy | 2,500 | $12.53 | $31,325.00 | filing |
| 2026-05-08 | SCHLACKMAN SCOTT | Buy | 2,500 | $12.65 | $31,625.00 | filing |
| 2026-03-25 | Chard Daniel R· Chairman & CEO | Tax withholding | 20,095 | $9.59 | $192,711.05 | filing |
| 2026-03-25 | Maloney James P.· Chief Financial Officer | Tax withholding | 3,224 | $9.59 | $30,918.16 | filing |
| 2026-03-25 | MacKenzie Jonathan Barrett· VP, Finance & CAO | Tax withholding | 862 | $9.59 | $8,266.58 | filing |
| 2026-03-25 | Chard Daniel R· Chairman & CEO | Award | 36,968 | $0.00 | $0.00 | filing |
| 2026-03-25 | MacKenzie Jonathan Barrett· VP, Finance & CAO | Award | 10,830 | $0.00 | $0.00 | filing |
| 2026-03-25 | Maloney James P.· Chief Financial Officer | Award | 34,344 | $0.00 | $0.00 | filing |
| 2026-03-25 | Maloney James P.· Chief Financial Officer | Award | 1,014 | $0.00 | $0.00 | filing |
| 2026-03-25 | Chard Daniel R· Chairman & CEO | Award | 4,827 | $0.00 | $0.00 | filing |
| 2026-03-20 | Chard Daniel R· Chairman & CEO | Buy | 17,678 | $10.11 | $178,724.58 | filing |
| 2026-03-17 | Chard Daniel R· Chairman & CEO | Tax withholding | 2,638 | $10.05 | $26,511.90 | filing |
| 2026-03-17 | Maloney James P.· Chief Financial Officer | Tax withholding | 482 | $10.05 | $4,844.10 | filing |
| 2026-03-17 | MacKenzie Jonathan Barrett· VP, Finance & CAO | Tax withholding | 70 | $10.05 | $703.50 | filing |
| 2026-03-13 | Chard Daniel R· Chairman & CEO | Tax withholding | 7,075 | $9.62 | $68,061.50 | filing |
| 2026-03-13 | Maloney James P.· Chief Financial Officer | Tax withholding | 918 | $9.62 | $8,831.16 | filing |
| 2026-03-13 | MacKenzie Jonathan Barrett· VP, Finance & CAO | Tax withholding | 198 | $9.62 | $1,904.76 | filing |
| 2025-06-25 | BROWN JEFFREY J | Award | 9,449 | $13.39 | $126,528.24 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.